ReviewInternational journal of molecular sciences2026
Antioxidative and Anti-Inflammatory Mechanisms of Quercetin in the Prevention of Secondary Diabetes Complications.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a chronic metabolic disorder linked with several microvascular and macrovascular complications and is one of the major causes of morbidity and mortality worldwide. Uncontrolled hyperglycemia is well known to increase oxidative and inflammatory responses. Further, activation of the polyol pathway and protein kinase C (PKC), and formation of advanced glycation end-products (AGEs) and their interaction with AGE receptors (RAGEs) can cause tissue dysfunction and damage, leading to secondary diabetes complications such as diabetic retinopathy, neuropathy, nephropathy, cardiovascular complications, and cataractogenesis. Several plant products have been shown to exert potential glucose-lowering effects due to their strong antioxidant and anti-inflammatory properties. Quercetin, a naturally occurring flavonoid abundant in fruits and vegetables, has attracted considerable interest because of its antioxidant, anti-inflammatory, and cytoprotective properties. Recent studies indicate the therapeutic potential of quercetin for controlling secondary diabetes complications. Various preclinical studies suggest that quercetin prevents the production of reactive oxygen species, suppresses NF-κB-mediated inflammatory signaling, activates Nrf-2-mediated antioxidant enzymes, and inhibits AGE-RAGE interactions. These actions of quercetin have been shown to prevent the production of pro-inflammatory cytokines, enhance endogenous antioxidant defenses, and attenuate the pathological consequences of diabetes complications. Although preclinical findings convincingly support the protective effects of quercetin across multiple diabetic complications, clinical findings remain limited and heterogeneous. Further, randomized clinical trials, long-term safety studies, and bioavailability studies are needed to determine its therapeutic effectiveness in clinical practice. In this review, we discuss recent findings on how quercetin prevents various secondary complications of diabetes. We further discuss how quercetin could serve as a promising multi-target adjunctive therapy by addressing the oxidative and inflammatory mechanisms underlying diabetic complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.